Conditions: Anxiety Disorders
Keywords: Generalized Anxiety Disorder GAD Anxiety
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 369
Healthy volunteers: no

Brief summary:
The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.

Detailed description:

Arms:
arm 1: AZD7325 5mg twice daily arm 2: AZD7325 15mg twice daily arm 3: Lorazepam 2mg twice daily arm 4: Placebo

Interventions: intervention 1: AZD7325 intervention 2: AZD7325 intervention 3: Lorazepam intervention 4: Placebo
Intervention descriptions: intervention 1: 4 tablets and 1 capsule taken twice a day for 28 days intervention 2: 4 tablets and 1 capsule taken twice a day for 28 days intervention 3: 4 tablets and 1 capsule taken twice a day for 28 days intervention 4: 4 tablets and 1 capsule taken twice a day for 28 days

Protocol document: